Suppression of Uterine and Placental Ferroptosis by N-Acetylcysteine in a Rat Model of Polycystic Ovary Syndrome
November 2021
in “
Molecular Human Reproduction
”
TLDR N-acetylcysteine may help treat uterine and placental issues in PCOS.
The study investigated the effects of N-acetylcysteine (NAC) on uterine and placental ferroptosis in a rat model of polycystic ovary syndrome (PCOS) with hyperandrogenism and insulin resistance. NAC was found to attenuate ferroptosis in the uterus and placenta, with dose-dependent increases in anti-ferroptosis gene content and increased glutathione peroxidase 4 protein levels in the placenta. While NAC did not fully reverse mitochondria-morphological abnormalities in the uterus, it partially did so in the placenta. NAC also normalized specific mRNA expressions related to uterine and placental function. These findings suggested that NAC could be a potential therapeutic strategy for treating uterine and placental dysfunction in PCOS-related conditions.